• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Alcobra Ltd. (ADHD)

    -NasdaqGM
    7.94 Up 0.18(2.32%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.76
    Open:7.76
    Bid:6.00 x 100
    Ask:10.04 x 100
    1y Target Est:20.40
    Beta:0.294452
    Earnings Date:Oct 21 - Oct 28 (Est.)
    Day's Range:7.59 - 8.22
    52wk Range:3.12 - 21.53
    Volume:203,029
    Avg Vol (3m):274,340
    Market Cap:160.41M
    P/E (ttm):N/A
    EPS (ttm):-1.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ADHDUp 2.32%160.41M
    JNJDown 1.09%263.54B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.15
    Quarterly EPS Est (Sep-15) :-0.31
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutama... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback